Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)

Market Cap	9.11B
Revenue (ttm)	3.97B
Net Income (ttm)	390.04M
Shares Out	989.20M
EPS (ttm)	0.39
PE Ratio	23.45
Forward PE	11.35
Dividend	0.30 (3.26%)
Ex-Dividend Date	Jun 5, 2024

Volume	14,253,300
Average Volume	22,011,916
Open	9.18
Previous Close	9.21
Day's Range	9.03 - 9.20
52-Week Range	8.60 - 14.80
Beta	0.22
RSI	41.55
Earnings Date	Apr 24, 2025

About SHE:002332

Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; and active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progesterone, non-hormone series, newchem API, and intermediates products. The company was founded in 1972 and is headquartered in Xianju, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 3,281
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002332

Financial Performance

In 2024, SHE:002332's revenue was 4.00 billion, a decrease of -2.98% compared to the previous year's 4.12 billion. Earnings were 397.18 million, a decrease of -29.46%.